- Home
- MAMA vs VYGR Comparison
MAMA vs VYGR Comparison
Compare MAMA & VYGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MAMA
- VYGR
- Stock Information
- Founded
- MAMA 2010
- VYGR 2013
- Country
- MAMA United States
- VYGR United States
- Employees
- MAMA N/A
- VYGR N/A
- Industry
- MAMA Specialty Foods
- VYGR Biotechnology: Pharmaceutical Preparations
- Sector
- MAMA Consumer Staples
- VYGR Health Care
- Exchange
- MAMA Nasdaq
- VYGR Nasdaq
- Market Cap
- MAMA 290.7M
- VYGR 342.5M
- IPO Year
- MAMA N/A
- VYGR 2015
- Fundamental
- Price
- MAMA $7.90
- VYGR $5.91
- Analyst Decision
- MAMA Strong Buy
- VYGR Strong Buy
- Analyst Count
- MAMA 4
- VYGR 9
- Target Price
- MAMA $10.50
- VYGR $16.44
- AVG Volume (30 Days)
- MAMA 466.3K
- VYGR 463.2K
- Earning Date
- MAMA 12-16-2024
- VYGR 11-12-2024
- Dividend Yield
- MAMA N/A
- VYGR N/A
- EPS Growth
- MAMA N/A
- VYGR N/A
- EPS
- MAMA 0.08
- VYGR 0.47
- Revenue
- MAMA $116,468,000.00
- VYGR $163,784,000.00
- Revenue This Year
- MAMA $18.91
- VYGR N/A
- Revenue Next Year
- MAMA $12.69
- VYGR N/A
- P/E Ratio
- MAMA $93.77
- VYGR $12.57
- Revenue Growth
- MAMA 17.20
- VYGR 3.40
- 52 Week Low
- MAMA $4.17
- VYGR $5.19
- 52 Week High
- MAMA $9.98
- VYGR $11.72
- Technical
- Relative Strength Index (RSI)
- MAMA 40.79
- VYGR 45.22
- Support Level
- MAMA $7.19
- VYGR $5.60
- Resistance Level
- MAMA $9.83
- VYGR $6.55
- Average True Range (ATR)
- MAMA 0.56
- VYGR 0.33
- MACD
- MAMA -0.23
- VYGR -0.04
- Stochastic Oscillator
- MAMA 25.54
- VYGR 32.76
About MAMA Mama's Creations Inc.
Mama`s Creations Inc is a marketer and manufacturer of fresh deli-prepared foods, found in over 8,400 grocery, mass, club, and convenience stores nationally. The company's broad product portfolio, born from a rich history in Italian foods, now consists of a variety of high-quality, fresh, clean, and easy-to-prepare foods to address the needs of both consumers and retailers.
About VYGR Voyager Therapeutics Inc.
Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.